跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
REVOLAX™ SUB-Q with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
Approved
STANDARD
REVOLAX™ SUB-Q with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
Hugel Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Aug 19, 2025
Approval ID
eb8baf7b7e84f28f
Company
Hugel Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
eb8baf7b7e84f28f
Product Name
REVOLAX™ SUB-Q with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
Artg Id
509129
Artg Name
Hugel Australia Pty Ltd - REVOLAX™ SUB-Q with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
Sponsor
Hugel Australia Pty Ltd
Company Detail Path
/organization/hugel-australia-pty-ltd
Artg Date
2025-08-15
Registration Type
Device
Therapeutic Good Type
Medical device
Licence Status
A
Licence Category
INC
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Aug 19, 2025
Approval ID
eb8baf7b7e84f28f
Type
Standard
Back to TGA Approvals
REVOLAX™ SUB-Q with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic - TGA Drug Approval Details
